Jamie Stockton
Stock Analyst at Wells Fargo
(2.31)
# 2,534
Out of 4,711 analysts
22
Total ratings
46.67%
Success rate
10.81%
Average return
Main Sectors:
Stocks Rated by Jamie Stockton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $175 → $200 | $9.44 | +2,018.64% | 5 | Oct 29, 2020 | |
| OMCL Omnicell | Maintains: Equal-Weight | $74 → $84 | $44.98 | +86.75% | 2 | Oct 28, 2020 | |
| HQY HealthEquity | Maintains: Overweight | $63 → $70 | $94.95 | -26.28% | 6 | Sep 9, 2020 | |
| EVH Evolent Health | Maintains: Overweight | $19 → $17 | $11.41 | +48.99% | 2 | Jan 8, 2020 | |
| MMS Maximus | Maintains: Equal-Weight | $83 → $81 | $72.94 | +11.05% | 3 | Jan 8, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | $140 → $160 | $197.27 | -18.89% | 2 | Feb 19, 2019 | |
| EHTH eHealth | Maintains: Market Perform | $18 → $24 | $8.32 | +188.46% | 2 | Oct 19, 2017 |
Teladoc Health
Oct 29, 2020
Maintains: Equal-Weight
Price Target: $175 → $200
Current: $9.44
Upside: +2,018.64%
Omnicell
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $74 → $84
Current: $44.98
Upside: +86.75%
HealthEquity
Sep 9, 2020
Maintains: Overweight
Price Target: $63 → $70
Current: $94.95
Upside: -26.28%
Evolent Health
Jan 8, 2020
Maintains: Overweight
Price Target: $19 → $17
Current: $11.41
Upside: +48.99%
Maximus
Jan 8, 2020
Maintains: Equal-Weight
Price Target: $83 → $81
Current: $72.94
Upside: +11.05%
IQVIA Holdings
Feb 19, 2019
Maintains: Outperform
Price Target: $140 → $160
Current: $197.27
Upside: -18.89%
eHealth
Oct 19, 2017
Maintains: Market Perform
Price Target: $18 → $24
Current: $8.32
Upside: +188.46%